<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MicroRNAs (miRs) are important regulators of gene expression in <z:mpath ids='MPATH_458'>normal</z:mpath> <z:mp ids='MP_0001532'>physiology</z:mp> and disease, and are widely misexpressed in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>A number of studies have identified miR-21 as an important promoter of <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>However, as is true of most miRs, the mechanisms behind the aberrant expression of miR-21 in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> are poorly understood </plain></SENT>
<SENT sid="3" pm="."><plain>Herein, we examine the regulation of miR-21 expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cells by the oncogenic epidermal growth factor (EGF)/Ras pathway and by Ets transcription factors, modulators of epithelial <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> that are frequently misexpressed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We show that EGF/Ras efficiently induces the miR-21 primary transcript, but this does not rapidly and simply translate into higher mature miR-21 levels </plain></SENT>
<SENT sid="5" pm="."><plain>Rather, induction of mature miR-21 by constitutive activation of this pathway is slow, is associated with only minimal activation of <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase, and may involve stimulation of post-transcriptional processing by mechanisms other than Dicer stabilization </plain></SENT>
<SENT sid="6" pm="."><plain>We further identify Ets transcription factors as modifiers of miR-21 expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The effects of Ets factors on miR-21 expression are cell context-dependent, and appear to involve both direct and indirect mechanisms </plain></SENT>
<SENT sid="8" pm="."><plain>The Ets factor Pea3 emerges from our studies as a consistent repressor of miR-21 transcription </plain></SENT>
<SENT sid="9" pm="."><plain>Overall, our studies identify a complex relationship between oncogenic pathways and steady-state miR-21 levels in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and highlight the need for greater understanding of the control of miR expression in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and other <z:mp ids='MP_0002054'>disease states</z:mp> </plain></SENT>
</text></document>